Skip to main content
. Author manuscript; available in PMC: 2017 Mar 2.
Published in final edited form as: Mol Neurobiol. 2015 Jan 10;53(2):995–1008. doi: 10.1007/s12035-014-9057-2

Fig. 7.

Fig. 7

Fenpropathrin increased DAT but decreased VMAT2 immunoreactivities in the SNc. a DAT immunoreactivity in the SNc of Con, Fen-60d, Fen-120d, DMSO, and Fen-ST groups. b Quantitative analysis of DAT immunoreactivity in the SNc. c VMAT2 immunoreactivity in the SNc of Con, Fen-60d, Fen-120d, DMSO-, and Fen-ST groups. d Quantitative analysis of VMAT2 immunoreactivity in the SNc (*P<0.05, compared to the Con group; #P<0.05, compared to DMSO group)